BTIG Reiterates Buy on Harrow, Maintains $63 Price Target

10/7/2026
Impact: 60
Healthcare

BTIG analyst Thomas Shrader has reiterated a Buy rating on Harrow (NASDAQ: HROW) and has maintained a price target of $63 for the stock.

AI summary, not financial advice

Share: